New Delhi: Scientists have developed a new lab-on-a-chip technique that may probably simplify and ease out cancer detection at an early stage.
This development can pave way for new treatments for this deadly disease.
Genomic biomarkers offer great potential for diagnostics and new forms of treatment, such as immunotherapy.
Miniaturised lab-on-a-chip approaches are prime candidates for developing viable diagnostic tests and instruments because they are small, need only limited test volumes and can be cost-effective.
A team of scientists and engineers from the University of California, Santa Cruz and Brigham Young University in the US have developed just such an approach capable of processing biomolecular samples from blood.
Their method can analyse and identify multiple targets on a silicon-based molecular detection platform.
